Virax Biolabs Group (VRAX) Stock Chart & Stock Price History → Please, take this warning seriously today (From Chaikin Analytics) (Ad) Free VRAX Stock Alerts $1.07 +0.02 (+1.90%) (As of 05:23 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Virax Biolabs Group Stock Price Performance5 Day Performance-9.32%1 Month Performance+74.30%3 Month Performance+9.18%6 Month Performance-46.23%Year-To-Date Performance-26.71%1 Year Performance-71.92% Receive VRAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself VRAX Stock Chart for Wednesday, June, 5, 2024 VRAX Chart by TradingView Virax Biolabs Group Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/04/2024$1.04$1.05+0.96%$1.10$0.89324,569 shs$1.63 million06/03/2024$1.18$1.04-11.86%$1.23$0.98270,470 shs$1.61 million05/31/2024$1.09$1.18+8.26%$1.29$0.92462,428 shs$1.83 million05/30/2024$0.92$1.09+18.48%$1.19$0.84800,087 shs$1.69 million05/29/2024$0.89$0.92+3.37%$0.92$0.8524,767 shs$1.43 million05/28/2024$0.90$0.89-1.11%$0.91$0.8430,007 shs$1.38 million Get the Latest News and Ratings for VRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. 05/27/2024$0.90$0.90$0.91$0.7536,700 shs$1.40 million05/24/2024$0.83$0.90+8.04%$0.91$0.7533,744 shs$1.40 million05/23/2024$0.86$0.83-2.57%$0.92$0.79101,339 shs$1.29 million05/22/2024$0.81$0.86+5.96%$0.86$0.8212,680 shs$1.33 million05/21/2024$0.83$0.81-2.78%$0.82$0.791,821 shs$1.25 million05/20/2024$0.84$0.83-1.13%$0.83$0.794,487 shs$1.29 million05/17/2024$0.78$0.83+6.27%$0.84$0.7922,162 shs$1.29 million05/16/2024$0.79$0.78-1.25%$0.82$0.7722,757 shs$1.22 million05/15/2024$0.76$0.79+5.10%$0.81$0.769,006 shs$1.23 million05/14/2024$0.79$0.76-4.83%$0.83$0.7437,222 shs$1.17 million05/13/2024$0.80$0.79-0.84%$0.82$0.7761,463 shs$1.23 million05/10/2024$0.69$0.80+15.94%$0.81$0.7073,910 shs$1.24 million05/09/2024$0.79$0.69-12.55%$0.79$0.6917,006 shs$1.07 million05/08/2024$0.73$0.79+8.08%$0.79$0.7330,666 shs$1.23 million05/07/2024$0.65$0.73+13.18%$0.84$0.65146,629 shs$1.14 million05/06/2024$0.61$0.65+5.07%$0.67$0.613,675 shs$1 million05/03/2024$0.61$0.61+0.64%$0.63$0.6029,397 shs$952,000.0005/02/2024$0.67$0.61-8.82%$0.67$0.619,439 shs$949,000.0005/01/2024$0.63$0.67+6.19%$0.67$0.6053,780 shs$1.04 million04/30/2024$0.63$0.63+0.21%$0.68$0.6312,785 shs$976,000.0004/29/2024$0.69$0.63-8.89%$0.71$0.6218,210 shs$974,000.0004/26/2024$0.70$0.69-1.43%$0.73$0.673,036 shs$1.07 million04/25/2024$0.65$0.70+7.53%$0.70$0.668,482 shs$1.09 million04/24/2024$0.66$0.65-1.06%$0.66$0.631,895 shs$1.01 million04/23/2024$0.68$0.66-3.24%$0.74$0.6139,713 shs$1.02 million04/22/2024$0.68$0.68+0.41%$0.71$0.685,284 shs$1.05 million04/19/2024$0.68$0.68+0.34%$0.74$0.648,234 shs$1.06 million04/18/2024$0.69$0.68-1.19%$0.74$0.684,769 shs$1.07 million04/17/2024$0.65$0.69+5.73%$0.78$0.6521,218 shs$1.07 million04/16/2024$0.68$0.65-3.61%$0.69$0.636,249 shs$1.01 million04/15/2024$0.74$0.68-8.78%$0.74$0.6157,610 shs$1.05 million04/12/2024$0.78$0.77-1.41%$0.82$0.7134,166 shs$1.19 million04/11/2024$0.78$0.78$0.83$0.777,306 shs$1.21 million04/10/2024$0.77$0.78+1.30%$0.82$0.765,138 shs$1.21 millionWhat’s Pelosi Buying Now? (Ad)They Make the Top Investors Look Like Amateurs They beat the market for three years straight… avoided some of the biggest crashes in stock market history... and perfectly played the booms in artificial intelligence, electric vehicles, and cryptocurrencies. One of their wealthiest members is even outperforming Warren Buffett.Discover where they're moving their money to now.04/09/2024$0.84$0.77-8.28%$0.81$0.7511,078 shs$1.20 million04/08/2024$0.82$0.84+2.38%$0.84$0.7910,866 shs$1.30 million04/05/2024$0.82$0.82-0.12%$0.88$0.8023,366 shs$1.27 million04/04/2024$0.87$0.82-5.63%$0.90$0.8160,482 shs$1.28 million04/03/2024$0.78$0.87+10.94%$0.89$0.7996,558 shs$1.35 million04/02/2024$0.74$0.78+6.69%$0.84$0.7236,700 shs$1.22 million04/01/2024$0.72$0.74+2.51%$0.79$0.7113,018 shs$1.14 million03/29/2024$0.72$0.72$0.78$0.719,360 shs$1.12 million03/28/2024$0.71$0.72+1.70%$0.78$0.719,315 shs$1.11 million03/27/2024$0.75$0.71-6.00%$0.80$0.7020,702 shs$1.09 million03/26/2024$0.75$0.75$0.80$0.7423,252 shs$1.16 million03/25/2024$0.78$0.75-3.85%$0.80$0.7519,640 shs$1.16 million03/22/2024$0.78$0.79+0.81%$0.81$0.7711,046 shs$1.22 million03/21/2024$0.79$0.78-1.66%$0.83$0.7714,700 shs$1.21 million03/20/2024$0.81$0.79-2.13%$0.86$0.7720,864 shs$1.23 million03/19/2024$0.84$0.81-3.40%$0.81$0.813,092 shs$1.26 million03/18/2024$0.84$0.84+0.36%$0.88$0.8312,042 shs$1.30 million03/15/2024$0.85$0.85-0.51%$0.88$0.8131,775 shs$1.31 million03/14/2024$0.85$0.85$0.89$0.844,721 shs$1.32 million03/13/2024$0.87$0.85-1.97%$0.90$0.8525,381 shs$1.32 million03/12/2024$0.87$0.87-0.33%$0.91$0.8715,546 shs$1.34 million03/11/2024$0.89$0.87-2.25%$0.93$0.8726,465 shs$1.35 million03/08/2024$0.95$0.90-4.79%$0.97$0.8781,093 shs$1.40 million03/07/2024$0.98$0.95-3.54%$1.01$0.9360,931 shs$1.47 million03/06/2024$0.98$0.98$1.04$0.9560,322 shs$1.52 million03/05/2024$0.97$0.98+1.03%$1.04$0.9849,984 shs$1.52 million03/04/2024$1.00$0.97-3.00%$1.04$0.9278,276 shs$1.50 million Related Companies: MyMD Pharmaceuticals Stock Chart Navidea Biopharmaceuticals Stock Chart IDEXX Laboratories Stock Chart Lantheus Stock Chart QuidelOrtho Stock Chart Neogen Stock Chart Celldex Therapeutics Stock Chart Intellia Therapeutics Stock Chart Myriad Genetics Stock Chart Achieve Life Sciences Stock Chart Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRAX) was last updated on 6/5/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press| SponsoredProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings| SponsoredPlease, take this warning seriously todayWall Street Legend Warns "Mass Bank Run" is Coming Man who predicted 2023 bank run warns it could soon get ...Chaikin Analytics| SponsoredThe Petrodollar Scheme Comes to an EndThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals| SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises| Sponsored[Webinar] Understanding Covered CallsDiscover the details of this option-selling strategy.OIC| SponsoredWhat’s Pelosi Buying Now?They Make the Top Investors Look Like Amateurs They beat the market for three years straight… avoided some ...Altimetry| Sponsored[Urgent!] Generational Wealth GameplanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan ...Crypto 101 Media| Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.